Literature DB >> 8537676

Population pharmacokinetics of didanosine in patients with human immunodeficiency virus infection.

G E Harb, J W Mandema, T Delahunty, N B Benowitz, R Coleman, L B Sheiner, M A Jacobson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8537676     DOI： 10.1093/infdis/173.1.273

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  3 in total

1.  Population pharmacokinetic analysis of lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAART.

Authors:  Xavière Panhard; Mayeule Legrand; Anne-Marie Taburet; Bertrand Diquet; Cécile Goujard; France Mentré
Journal:  Eur J Clin Pharmacol       Date:  2007-08-11       Impact factor: 2.953

Review 2.  Application and impact of population pharmacokinetics in the assessment of antiretroviral pharmacotherapy.

Authors:  Jeffrey S Barrett; Line Labbé; Marc Pfister
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 5.577

3.  Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators.

Authors:  X J Zhou; L B Sheiner; R T D'Aquila; M D Hughes; M S Hirsch; M A Fischl; V A Johnson; M Myers; J P Sommadossi
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.